Correlation Between Pmv Pharmaceuticals and Passage Bio
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Passage Bio, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Passage Bio.
Diversification Opportunities for Pmv Pharmaceuticals and Passage Bio
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pmv and Passage is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Passage Bio go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Passage Bio
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.47 times more return on investment than Passage Bio. However, Pmv Pharmaceuticals is 2.11 times less risky than Passage Bio. It trades about 0.21 of its potential returns per unit of risk. Passage Bio is currently generating about 0.0 per unit of risk. If you would invest 88.00 in Pmv Pharmaceuticals on May 30, 2025 and sell it today you would earn a total of 56.00 from holding Pmv Pharmaceuticals or generate 63.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Passage Bio
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Passage Bio |
Pmv Pharmaceuticals and Passage Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Passage Bio
The main advantage of trading using opposite Pmv Pharmaceuticals and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.| Pmv Pharmaceuticals vs. Alx Oncology Holdings | Pmv Pharmaceuticals vs. AN2 Therapeutics | Pmv Pharmaceuticals vs. C4 Therapeutics | Pmv Pharmaceuticals vs. Mineralys Therapeutics, Common |
| Passage Bio vs. Q32 Bio | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |